JP2016535270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535270A5 JP2016535270A5 JP2016533958A JP2016533958A JP2016535270A5 JP 2016535270 A5 JP2016535270 A5 JP 2016535270A5 JP 2016533958 A JP2016533958 A JP 2016533958A JP 2016533958 A JP2016533958 A JP 2016533958A JP 2016535270 A5 JP2016535270 A5 JP 2016535270A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- proteins
- protein
- protein kinase
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 49
- 108090000623 proteins and genes Proteins 0.000 claims 49
- 206010028980 Neoplasm Diseases 0.000 claims 37
- 239000000090 biomarker Substances 0.000 claims 18
- 238000000034 method Methods 0.000 claims 17
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 16
- 201000002528 pancreatic cancer Diseases 0.000 claims 16
- 239000000523 sample Substances 0.000 claims 14
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 claims 13
- 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 claims 11
- 101710110794 Homeodomain-interacting protein kinase 1 Proteins 0.000 claims 11
- 230000009822 protein phosphorylation Effects 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 claims 7
- 108010001441 Phosphopeptides Proteins 0.000 claims 7
- 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 claims 7
- 101710112530 Serine/threonine-protein kinase MRCK alpha Proteins 0.000 claims 7
- 230000035945 sensitivity Effects 0.000 claims 7
- 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 claims 6
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 claims 6
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 6
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 6
- 230000001394 metastastic effect Effects 0.000 claims 5
- 206010061289 metastatic neoplasm Diseases 0.000 claims 5
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 claims 4
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 230000026731 phosphorylation Effects 0.000 claims 4
- 238000006366 phosphorylation reaction Methods 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 101001031598 Dictyostelium discoideum Probable serine/threonine-protein kinase fhkC Proteins 0.000 claims 3
- 230000027455 binding Effects 0.000 claims 3
- 239000007853 buffer solution Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 210000004923 pancreatic tissue Anatomy 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 230000009870 specific binding Effects 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 claims 2
- 102000012334 Integrin beta4 Human genes 0.000 claims 2
- 108010022238 Integrin beta4 Proteins 0.000 claims 2
- 108700027649 Mitogen-Activated Protein Kinase 3 Proteins 0.000 claims 2
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 claims 2
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 claims 2
- 102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 claims 2
- 101710102899 Tyrosine-protein kinase Fyn Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 2
- 230000029087 digestion Effects 0.000 claims 2
- 230000003828 downregulation Effects 0.000 claims 2
- 230000003827 upregulation Effects 0.000 claims 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims 1
- 108010069682 CSK Tyrosine-Protein Kinase Proteins 0.000 claims 1
- 102100028003 Catenin alpha-1 Human genes 0.000 claims 1
- 101710106615 Catenin alpha-1 Proteins 0.000 claims 1
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 claims 1
- 101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 claims 1
- 102100022975 Glycogen synthase kinase-3 alpha Human genes 0.000 claims 1
- 102000015616 Histone Deacetylase 1 Human genes 0.000 claims 1
- 108010024124 Histone Deacetylase 1 Proteins 0.000 claims 1
- 108010023981 Histone Deacetylase 2 Proteins 0.000 claims 1
- 102100039999 Histone deacetylase 2 Human genes 0.000 claims 1
- 102000009331 Homeodomain Proteins Human genes 0.000 claims 1
- 108010048671 Homeodomain Proteins Proteins 0.000 claims 1
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 claims 1
- 101100087590 Homo sapiens RICTOR gene Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000014748 Junctional Adhesion Molecules Human genes 0.000 claims 1
- 108010064064 Junctional Adhesion Molecules Proteins 0.000 claims 1
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 claims 1
- 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 claims 1
- 108040008097 MAP kinase activity proteins Proteins 0.000 claims 1
- 102000019149 MAP kinase activity proteins Human genes 0.000 claims 1
- 102000043136 MAP kinase family Human genes 0.000 claims 1
- 108091054455 MAP kinase family Proteins 0.000 claims 1
- 101710166115 Mitogen-activated protein kinase 2 Proteins 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 108010008707 Mucin-1 Proteins 0.000 claims 1
- 102000003505 Myosin Human genes 0.000 claims 1
- 108060008487 Myosin Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 108010029869 Proto-Oncogene Proteins c-raf Proteins 0.000 claims 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 claims 1
- 102000046941 Rapamycin-Insensitive Companion of mTOR Human genes 0.000 claims 1
- 108700019586 Rapamycin-Insensitive Companion of mTOR Proteins 0.000 claims 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 claims 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 claims 1
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 229960002448 dasatinib Drugs 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108010049611 glycogen synthase kinase 3 alpha Proteins 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- AXTAPYRUEKNRBA-JTQLQIEISA-N n-[(2s)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=C(Cl)OC(C(=O)N[C@H](CN)CC=2C=C(F)C(F)=CC=2)=C1 AXTAPYRUEKNRBA-JTQLQIEISA-N 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 239000012474 protein marker Substances 0.000 claims 1
- 208000011581 secondary neoplasm Diseases 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 229960003787 sorafenib Drugs 0.000 claims 1
- 229960000235 temsirolimus Drugs 0.000 claims 1
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims 1
- 229960000237 vorinostat Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1314485.2 | 2013-08-13 | ||
| GBGB1314485.2A GB201314485D0 (en) | 2013-08-13 | 2013-08-13 | Materials and methods relating to pancreatic cancer |
| PCT/GB2014/052475 WO2015022530A2 (en) | 2013-08-13 | 2014-08-13 | Materials and methods relating to pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016535270A JP2016535270A (ja) | 2016-11-10 |
| JP2016535270A5 true JP2016535270A5 (https=) | 2017-12-28 |
Family
ID=49262110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533958A Pending JP2016535270A (ja) | 2013-08-13 | 2014-08-13 | 膵臓癌に関連する物質及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160195536A1 (https=) |
| EP (1) | EP3033624A2 (https=) |
| JP (1) | JP2016535270A (https=) |
| CN (1) | CN105637367A (https=) |
| CA (1) | CA2920946A1 (https=) |
| GB (1) | GB201314485D0 (https=) |
| WO (1) | WO2015022530A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107923918A (zh) * | 2015-09-09 | 2018-04-17 | 私募蛋白质体公司 | 用于开发个性化药物治疗计划和基于蛋白质组谱的靶向药物开发的方法 |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| JP2020514684A (ja) * | 2016-12-20 | 2020-05-21 | トリート４ライフ アーベー | 質量分析によってｂｒａｆ突然変異および野生型ｂｒａｆタンパク質を定める方法 |
| CN112585470A (zh) * | 2018-06-21 | 2021-03-30 | 乌得勒支大学控股有限责任公司 | 用于监测样品中激酶活性的方法 |
| CN111066727B (zh) * | 2019-12-20 | 2021-08-27 | 中国人民解放军陆军军医大学 | 在低氧性血睾屏障通透中作用机制的小鼠模型构建方法 |
| IT202000016807A1 (it) * | 2020-07-10 | 2022-01-10 | Humanitas Mirasole Spa | Peptidi associati a tumore e loro impiego |
| JPWO2022154037A1 (https=) * | 2021-01-14 | 2022-07-21 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2259800T3 (es) | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| WO2003016861A2 (en) | 2001-08-14 | 2003-02-27 | President And Fellows Of Harvard College | Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| WO2004055519A2 (en) * | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Specific markers for pancreatic cancer |
| CN1726395A (zh) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | 胰腺癌的特异标记 |
| US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
| DE102006056784A1 (de) * | 2006-12-01 | 2008-06-05 | Meyer, Helmut E., Prof.Dr. | Biomarker für die Diagnose von Pankreaskrebs |
| GB0704764D0 (en) | 2007-03-12 | 2007-04-18 | Electrophoretics Ltd | Isobarically labelled reagents and methods of their use |
| WO2009146545A1 (en) * | 2008-06-05 | 2009-12-10 | University Health Network | Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| EP2391891A1 (en) * | 2009-01-27 | 2011-12-07 | Proteogenix, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| US20130023436A1 (en) * | 2010-01-15 | 2013-01-24 | Bryan William Jones | Disease diagnosis and treatment using computational molecular phenotyping |
| WO2011092338A1 (en) * | 2010-02-01 | 2011-08-04 | Ab Science | Combined treatment of pancreatic cancer with gemcitabine and masitinib |
| CN102947706B (zh) * | 2010-04-19 | 2018-04-13 | 生物标志物策略公司 | 预测药物敏感性、抗性和疾病进展的组合物和方法 |
| AU2011260390B2 (en) * | 2010-06-01 | 2016-11-24 | Ernst-Moritz-Arndt Universitat Greifswald | Means and methods for diagnosing pancreatic cancer in a subject |
| EP2582727B8 (en) * | 2010-06-16 | 2017-04-19 | University of Pittsburgh- Of the Commonwealth System of Higher Education | Antibodies to endoplasmin and their use |
| US20140222443A1 (en) * | 2011-06-07 | 2014-08-07 | Kathleen Danenberg | Molecular profiling for cancer |
-
2013
- 2013-08-13 GB GBGB1314485.2A patent/GB201314485D0/en not_active Ceased
-
2014
- 2014-08-13 CA CA2920946A patent/CA2920946A1/en not_active Abandoned
- 2014-08-13 WO PCT/GB2014/052475 patent/WO2015022530A2/en not_active Ceased
- 2014-08-13 EP EP14755897.7A patent/EP3033624A2/en not_active Withdrawn
- 2014-08-13 JP JP2016533958A patent/JP2016535270A/ja active Pending
- 2014-08-13 US US14/912,299 patent/US20160195536A1/en not_active Abandoned
- 2014-08-13 CN CN201480056359.9A patent/CN105637367A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016535270A5 (https=) | ||
| US20220214344A1 (en) | Method, array and use thereof | |
| Chen et al. | Prognostic fifteen-gene signature for early stage pancreatic ductal adenocarcinoma | |
| Vargas et al. | Biomarker development in the precision medicine era: lung cancer as a case study | |
| CA2974775C (en) | Biomarkers for pancreatic cancer | |
| Zhou et al. | Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives | |
| Cao et al. | Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts | |
| CN114137205A (zh) | 用于检测食物变态反应的肽、试剂和方法 | |
| KR20140040118A (ko) | 췌장암의 존재를 결정하기 위한 방법, 어레이 및 그의 용도 | |
| KR20210100068A (ko) | 췌장암 진단용 바이오마커 패널 및 그 용도 | |
| JP6104796B2 (ja) | 方法、アレイ、およびこれらの使用 | |
| JP2016536568A5 (https=) | ||
| Zhang et al. | Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ‐Based Quantitative Proteomic Analysis | |
| Loch et al. | Use of high density antibody arrays to validate and discover cancer serum biomarkers | |
| AU2014247083A1 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| JP2016519767A5 (https=) | ||
| Park et al. | Evolutionary identification of affinity peptides for the detection of sepsis biomarker procalcitonin | |
| Zhou et al. | Oncoproteomics: trials and tribulations | |
| EP4314347A1 (en) | Proteogenomic analysis of non-small cell lung cancer | |
| Panis et al. | How can proteomics reach cancer biomarkers? | |
| Wang et al. | Prospective proteomics for discovering biomarkers in lung adenocarcinoma: a literature review | |
| KR102131860B1 (ko) | 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물 | |
| US20210080465A1 (en) | SH2 domain-based prognostic biomarker for chronic lymphocytic leukemia | |
| Jeon et al. | C-reactive protein as a parameter for defining normal blood samples in identification and evaluation of serological biomarkers | |
| Baron | Application of proteomics to cancer therapy |